Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC)

Cell lineage reprogramming is the main approach for cancer cells to acquire drug resistance and escape targeted therapy. The use of potent targeted therapies in cancers has led to the development of highly aggressive carcinoma, including neuroendocrine prostate cancer (NEPC). Although metabolic repr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Huan, Liu, Zhixiao, Gao, Dajun, Li, Peizhang, Shen, Yanting, Sun, Yi, Xu, Lingfan, Song, Nan, Wang, Yue, Zhan, Ming, Gao, Xu, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933846/
https://www.ncbi.nlm.nih.gov/pubmed/35219875
http://dx.doi.org/10.1016/j.molmet.2022.101466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933846/
https://www.ncbi.nlm.nih.gov/pubmed/35219875
http://dx.doi.org/10.1016/j.molmet.2022.101466

Ejemplares similares